Doctor profile · Federal record

Dr. RAMZI SHAQAREQ, MD

Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · ST AUGUSTINE, FL

  • NPI 1598715229
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 29 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
100 WHETSTONE PL, SUITE 208
ST AUGUSTINE, FL 320865774
(904) 819-6800
fax (904) 819-6700

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
November 19, 2008
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RP1001X — NUCC code
State license (1)
Florida #ME91451
Medicaid
FL #272824900

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1598715229. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,924
Distinct HCPCS
8
Medicare allowed
$184,539
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 948 442 $123
94727 Test to determine lung volumes using gas dilution or washout 247 244 $41
94729 Test to examine how well the lungs exchange gases 247 244 $53
94060 Test to measure expiratory airflow and volume changes before and after medication administration 244 241 $37
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older) 88 78 $118
99205 New patient office or other outpatient visit, 60-74 minutes 67 67 $206
95810 Sleep study in sleep lab (6 years or older) 43 40 $116
99204 New patient office or other outpatient visit, 45-59 minutes 40 40 $164

In context: peer comparison

Among 4 peers in this city , average services per provider: 193. This provider delivers 10.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$946
Transactions
49
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
GlaxoSmithKline, LLC. 14 $235.11
AstraZeneca Pharmaceuticals LP 10 $211.20
Boehringer Ingelheim Pharmaceuticals, Inc. 8 $153.39
Takeda Pharmaceuticals U.S.A., Inc. 5 $98.07
Regeneron Healthcare Solutions, Inc. 3 $69.19
Mylan Specialty L.P. 3 $54.08
Pulmonx Corporation 2 $42.91
3B Medical, Inc. 1 $26.91
Grifols USA, LLC 1 $19.92
Insmed, Inc. 1 $19.47
Inspire Medical Systems, Inc. 1 $16.13

By nature of payment

Food and Beverage
$946

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,504
Patients
395
Total drug cost
$761,547
Drug Type Claims Patients Total cost
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 527 96 $475,934
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 251 106 $10,144
Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) Brand 153 29 $97,594
Breo Ellipta (Fluticasone/Vilanterol) Brand 94 15 $37,612
Zolpidem Tartrate Generic 70 29 $613
Incruse Ellipta (Umeclidinium Bromide) Brand 68 11 $28,062
Symbicort (Budesonide/Formoterol Fumarate) Brand 59 16 $35,778
Montelukast Sodium Generic 51 12 $213
Ventolin Hfa (Albuterol Sulfate) Brand 50 14 $3,007
Prednisone Generic 44 28 $213